HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Activation of FGF receptors is a new mechanism by which strontium ranelate induces osteoblastic cell growth.

AbstractBACKGROUND/AIMS:
Strontium ranelate (SrRan) is an anti-osteoporotic treatment that reduces the risk of vertebral and hip fractures. Recent in vitro studies suggest that the effect of strontium ranelate on osteoblastic cell growth likely involves two processes including activation of the calcium sensing receptor (CaSR) and a yet undefined mechanism. In the present study, we investigated the CaSR-independent molecular mechanism by which SrRan stimulates osteoblast growth.
METHODS:
MC3T3-E1 and primary osteoblastic cells, specific inhibitors of receptor tyrosine kinases (RTK) and western blot analysis were used to characterize the CaSR-independent mechanism in osteoblastic cells.
RESULTS:
A selective inhibitor of FGF receptor but not other RTK inhibitors markedly blunted cell growth induced by SrRan in osteoblastic cells. Associated with this observation, SrRan induced rapid activation of FGFR signaling pathways such as PLCĪ³, FRS2, Akt, ERK1,2 and p38. FGFR-dependent stimulation of osteogenic cell growth was also observed with other cations but not with neomycin, a selective CaSR agonist. Also, in cultured conditions used in this study, MC3T3-E1 cells and primary osteoblasts did not express the CaSR.
CONCLUSION:
data presented in this study suggest that activation of FGFRs is a new potential mechanism by which strontium can stimulate osteoblastic cell growth. Activation of FGFR-dependent cell growth is also observed in response to other cations suggesting that activation of FGF receptors is a new cation sensing mechanism in osteoblasts.
AuthorsJoseph Caverzasio, Cyril Thouverey
JournalCellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology (Cell Physiol Biochem) Vol. 27 Issue 3-4 Pg. 243-50 ( 2011) ISSN: 1421-9778 [Electronic] Germany
PMID21471713 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2011 S. Karger AG, Basel.
Chemical References
  • Bone Density Conservation Agents
  • FRS2alpha protein, mouse
  • Membrane Proteins
  • Organometallic Compounds
  • Receptors, Calcium-Sensing
  • Receptors, Fibroblast Growth Factor
  • Thiophenes
  • strontium ranelate
  • Proto-Oncogene Proteins c-akt
  • Mitogen-Activated Protein Kinase 1
  • Mitogen-Activated Protein Kinase 3
  • p38 Mitogen-Activated Protein Kinases
Topics
  • Animals
  • Bone Density Conservation Agents (pharmacology)
  • Cell Proliferation (drug effects)
  • Cells, Cultured
  • Membrane Proteins (genetics, metabolism)
  • Mice
  • Mice, Inbred C57BL
  • Mitogen-Activated Protein Kinase 1 (genetics, metabolism)
  • Mitogen-Activated Protein Kinase 3 (genetics, metabolism)
  • Organometallic Compounds (pharmacology)
  • Osteoblasts (cytology, drug effects, metabolism)
  • Proto-Oncogene Proteins c-akt (genetics, metabolism)
  • Receptors, Calcium-Sensing (agonists, metabolism)
  • Receptors, Fibroblast Growth Factor (antagonists & inhibitors, metabolism)
  • Signal Transduction
  • Thiophenes (pharmacology)
  • p38 Mitogen-Activated Protein Kinases (genetics, metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: